冠心病心脏康复基层合理用药指南

2021-03-25 中华医学会 中华全科医师杂志.2021.20(3):311-320.

心脏康复是指应用药物、运动、营养、精神心理及行为干预戒烟限酒五大处方综合性医疗措施,使心血管疾病患者获得正常或者接近正常的生活状态,降低再发心血管事件和猝死风险,尽早恢复体力和回归社会。心脏康复融合了

中文标题:

冠心病心脏康复基层合理用药指南

发布机构:

中华医学会

发布日期:

2021-03-25

简要介绍:

心脏康复是指应用药物、运动、营养、精神心理及行为干预戒烟限酒五大处方综合性医疗措施,使心血管疾病患者获得正常或者接近正常的生活状态,降低再发心血管事件和猝死风险,尽早恢复体力和回归社会。心脏康复融合了心血管医学、运动医学、营养医学、心身医学和行为医学等多学科交叉领域,为心血管疾病患者在急性期、恢复期、维持期以及整个生命过程中提供生理⁃心理⁃社会综合医疗干预和风险把控,涵盖心血管事件发生前预防和发生后治疗与康复,是心血管疾病全程管理和全生命周期健康服务的重要组成部分。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (25)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1182636, encodeId=1cb71182636f6, content=己学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:01:28 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179302, encodeId=377c11e9302cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Fri Dec 31 14:54:05 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084872, encodeId=030810848e209, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:28:07 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081201, encodeId=59b8108120164, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c425399837, createdName=Rivendell123, createdTime=Fri Dec 17 17:02:05 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080186, encodeId=eef61080186d0, content=非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68876192321, createdName=liukefa_8815, createdTime=Wed Dec 15 07:35:24 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2022-01-09 ms6000000225486324

    己学习,很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1182636, encodeId=1cb71182636f6, content=己学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:01:28 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179302, encodeId=377c11e9302cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Fri Dec 31 14:54:05 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084872, encodeId=030810848e209, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:28:07 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081201, encodeId=59b8108120164, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c425399837, createdName=Rivendell123, createdTime=Fri Dec 17 17:02:05 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080186, encodeId=eef61080186d0, content=非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68876192321, createdName=liukefa_8815, createdTime=Wed Dec 15 07:35:24 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-31 1e129e46m43(暂无匿称)

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1182636, encodeId=1cb71182636f6, content=己学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:01:28 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179302, encodeId=377c11e9302cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Fri Dec 31 14:54:05 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084872, encodeId=030810848e209, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:28:07 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081201, encodeId=59b8108120164, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c425399837, createdName=Rivendell123, createdTime=Fri Dec 17 17:02:05 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080186, encodeId=eef61080186d0, content=非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68876192321, createdName=liukefa_8815, createdTime=Wed Dec 15 07:35:24 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-27 ms6000000225486324

    学习了,很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1182636, encodeId=1cb71182636f6, content=己学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:01:28 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179302, encodeId=377c11e9302cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Fri Dec 31 14:54:05 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084872, encodeId=030810848e209, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:28:07 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081201, encodeId=59b8108120164, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c425399837, createdName=Rivendell123, createdTime=Fri Dec 17 17:02:05 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080186, encodeId=eef61080186d0, content=非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68876192321, createdName=liukefa_8815, createdTime=Wed Dec 15 07:35:24 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-17 Rivendell123

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1182636, encodeId=1cb71182636f6, content=己学习,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Sun Jan 09 22:01:28 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179302, encodeId=377c11e9302cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01af1957237, createdName=1e129e46m43(暂无匿称), createdTime=Fri Dec 31 14:54:05 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084872, encodeId=030810848e209, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/cc1287d895a346908d9358058cdb61ff/5ef3f7950426411ea0c9966d76a74064.jpg, createdBy=1d315559103, createdName=ms6000000225486324, createdTime=Mon Dec 27 21:28:07 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081201, encodeId=59b8108120164, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c425399837, createdName=Rivendell123, createdTime=Fri Dec 17 17:02:05 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080186, encodeId=eef61080186d0, content=非常使用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68876192321, createdName=liukefa_8815, createdTime=Wed Dec 15 07:35:24 CST 2021, time=2021-12-15, status=1, ipAttribution=)]
    2021-12-15 liukefa_8815

    非常使用

    0